ALK-1 Positive Anaplastic Large Cell Lymphoma Presenting as Extensive and Exclusive Osseous Involvement: Report of a Rare Association and Review of Literature
Published: January 1, 2018 | DOI: https://doi.org/10.7860/JCDR/2018/31109.11040
Swetha Lakshmi Narla, Ann Joseph Kurian, Annapurneswari Subramanyan, Ashok Parameswaran
1. Junior Consultant, Department of Histopathology, Apollo Cancer Institute, Chennai, Tamil Nadu, India.
2. Senior Consultant, Department of Histopathology, Apollo Cancer Institute, Chennai, Tamil Nadu, India.
3. Senior Consultant and Head, Department of Histopathology, Apollo Cancer Institute, Chennai, Tamil Nadu, India.
4. Chief of Laboratory Service, Department of Histopathology, Apollo Cancer Institute, Chennai, Tamil Nadu, India.
Correspondence
Dr. Swetha Lakshmi Narla,
320 Anna Salai, Teynampet, Chennai-600035, Tamil Nadu, India.
E-mail: drswetha.gmc2k2@gmail.com
Primary Bone Lymphomas (PBLs) are uncommon. Most of these tumours are Non Hodgkin Lymphoma (NHL) with Diffuse Large B-cell Lymphoma (DLBCL) being the most common. Anaplastic Large Cell Lymphoma (ALCL) constitutes approximately 2% of all NHL and involves both nodal and extra nodal sites. ALCL presenting as exclusive and extensive bone involvement is rare. We report a case of 31-year-old man who presented with osseous involvement only. Imaging showed multiple lytic lesions involving the vertebral column, ribs and sternum. Clinical differential diagnosis included osteomyelitis and bone neoplasms. Histopathology and immunohistochemistry of the lytic lesion proved it to be Anaplastic Lymphoma Kinase (ALK-1) positive ALCL. The patient relapsed three months after completion of six cycles of combination chemotherapy with Cyclophosphamide, Hydroxydaunorubicin, Vincristine and Prednisone (CHOP).
[
FULL TEXT ] | [ PDF]